insiderdelta
CoverageForm 410-K10-Q8-K13D13G13F

AVTX Avalo Therapeutics, Inc. - 8-K

Filed May 5, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001534120-26-000028
No items extracted yet - this filing's body hasn't been ingested (or the item parser couldn't find structured headings).
AVTX 8-K filed 2026 · insiderdelta